L

Lexington Biosciences Holdings Corp
OTC:LXGTF

Watchlist Manager
Lexington Biosciences Holdings Corp
OTC:LXGTF
Watchlist
Price: 0.0001 USD
Market Cap: 38 USD

Net Margin
Lexington Biosciences Holdings Corp

0%
Current
0%
Average
3.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-170.9k
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Lexington Biosciences Holdings Corp
Glance View

Market Cap
38 USD
Industry
N/A

Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2017-06-01. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The firm is in the final stages of releasing the developed product for clinical studies. The firm's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.

LXGTF Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-170.9k
/
Revenue
0
What is the Net Margin of Lexington Biosciences Holdings Corp?

Based on Lexington Biosciences Holdings Corp's most recent financial statements, the company has Net Margin of 0%.

Back to Top